Author Search Results

1

Dual targeting of estrogen receptor α and estrogen-related receptor α: a novel endocrine therapy for endometrial cancer

by Mao X, Dong B, Gao M, Ruan G, Huang M, Braicu EI, Sehouli J, Sun P
Published 2019-08-01

Get full text

Article
2

Novel endocrine therapeutic strategy in endometrial carcinoma targeting estrogen-related receptor α by XCT790 and siRNA

by Sun PM, Mao XD, Gao M, Huang MM, Chen LL, Ruan GY, Huang WY, Braicu EI, Sehouli J
Published 2018-08-01

Get full text

Article
3

HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer – a study of the OVCAD Consortium

by Braicu EI, Luketina H, Richter R, Cacsire Castillo-Tong D, Lambrechts S, Mahner S, Concin N, Mentze M, Zeillinger R, Vergote I, Sehouli J
Published 2014-09-01

Get full text

Article
4

Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer

by Bourne, T., Braicu, E.I, Busschaert, P., Concin, N., Coosemans, A., Froyman, W., Han, S.N, Heremans, R., Lambrechts, D., Landolfo, C., Loverix, L., Neven, P., Olbrecht, S., Timmerman, D., Van Calster, B., Van Gorp, T., Van Nieuwenhuysen, E., Vanderstichele, A., Venken, T., Vergote, I., Wimberger, P.
Published 2022

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article